Valuation: Biogen Inc.

Market Cap 31.84B 27.77B 26.22B 23.81B 44.6B 3,055B 44.79B 314B 121B 1,553B 120B 117B 4,998B P/E 2026 *
35.1x
P/E 2027 * 19.1x
Enterprise Value 36.78B 32.07B 30.28B 27.5B 51.52B 3,529B 51.74B 363B 140B 1,794B 138B 135B 5,773B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.21x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.62%
1 week-0.76%
Current month-0.53%
1 month+1.39%
3 months+9.62%
6 months+18.21%
Current year+22.45%
1 week 213.54
Extreme 213.54
222.24
1 month 208.93
Extreme 208.9279
225.8
Current year 160.36
Extreme 160.3645
225.8
1 year 135.39
Extreme 135.39
225.8
3 years 110.04
Extreme 110.035
269.43
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

General Counsel

7,405 0.0050%
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%-0.76%+49.85%-14.92% 31.84B
-0.58%+0.43%+31.09%-4.81% 78.35B
-2.55%+6.99%+505.27%+47.92% 61.52B
-1.11%+5.08%-11.47%-33.91% 59.78B
+0.14%-1.20%-11.64%+24.21% 46.53B
-0.24%+1.22%+2.26%+151.03% 45.5B
-1.81%+3.16%+45.71%+110.57% 25.4B
+0.47%+3.26%-0.77%+142.41% 21.43B
+0.27%+1.96%+62.19%+102.81% 15.77B
-1.04%-8.05%+24.90%+133.39% 13.02B
Average -0.81%+1.17%+69.74%+65.87% 39.92B
Weighted average by Cap. -0.93%+2.01%+91.28%+43.31%

Financials

2026 *2027 *
Net sales 10.44B 9.11B 8.6B 7.81B 14.63B 1,002B 14.69B 103B 39.75B 509B 39.23B 38.36B 1,639B 10.66B 9.29B 8.78B 7.97B 14.93B 1,023B 14.99B 105B 40.56B 520B 40.04B 39.15B 1,673B
Net income 997M 869M 821M 745M 1.4B 95.65B 1.4B 9.83B 3.79B 48.63B 3.74B 3.66B 156B 1.86B 1.62B 1.53B 1.39B 2.6B 178B 2.61B 18.33B 7.07B 90.68B 6.98B 6.83B 292B
Net Debt 4.94B 4.3B 4.06B 3.69B 6.92B 474B 6.94B 48.69B 18.79B 241B 18.54B 18.13B 775B 2.42B 2.11B 1.99B 1.81B 3.39B 232B 3.4B 23.87B 9.21B 118B 9.09B 8.89B 380B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
18/09/26 US$215.50 -1.62% 2,636,086
17/09/26 US$219.05 +1.41% 836,707
16/09/26 US$216.01 -0.07% 606,493
15/09/26 US$216.17 -0.55% 756,047
14/09/26 US$217.36 +0.10% 629,931
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
215.50USD
Average target price
238.18USD
Spread / Average Target
+10.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!